Sema3G activates YAP and promotes VSMCs proliferation and migration via Nrp2/PlexinA1
Cellular Signalling · 2023-05 · 105 · 110613
DOI: 10.1016/j.cellsig.2023.110613 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2023-05. Verfasst von Xue-Yang Luo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Ch…. Hauptthemen laut MEDLINE: Semaphorins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
BACKGROUND: Diabetes exacerbates neointima formation after vascular procedures, manifested by accelerated proliferation and migration of vascular smooth muscle cells (VSMCs). Semaphorin 3G (Sema3G), secreted mainly from endothelial cells (ECs), regulates various cellular functions and vascular pathologies. However, the function and potential mechanism of ECs-derived Sema3G in VSMCs under diabetic condition remain unclear. OBJECTIVE: To investigate the role and the mechanism of ECs-derived Sema3G in the regulation of VSMCs proliferation and migration. RESULTS: ECs-derived Sema3G promoted human aortic SMCs (HASMCs) cell cycle progression and proliferation. Sema3G upregulated the expression of MMP2 and MMP9, which might explain the increased HASMCs migration by Sema3G. Inhibition of Nrp2/PlexinA1 mitigated the effect of Sema3G on promoting HASMCs proliferation and migration. Mechanistically, Sema3G inhibited LATS1 and activated YAP via Nrp2/PlexinA1. Verteporfin, an FDA-approved YAP pathway inhibitor, counteracted Sema3G-induced cyclin E and cyclin D1 expression. Besides, Sema3G expression was upregulated in ECs of diabetic mouse aortas. Serum Sema3G level was increased in type 2 diabetic patients and mice. Moreover, compared to chow diet-fed mice, high-fat diet (HFD)-fed obese mice showed thicker neointima and higher Sema3G expression in vasculature after femoral injury. CONCLUSIONS: Our results indicated that ECs-derived Sema3G under diabetic condition activated YAP and promoted HASMCs proliferation and migration via Nrp2/PlexinA1. Thus, inhibition of Sema3G may hold therapeutic potential against diabetes-associated intimal hyperplasia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology and Metabolism, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Endocrinology & Metabolism, Shanghai Jiao Tong University Affiliat…
- Institute for Developmental and Regenerative Cardiovascular Medicine, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: chenfengyuan@xinhuamed.com.cn.
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Luo, X. Y., Fu, X., Liu, F., Luo, J. Y., & Chen, A. F. (2023). Sema3G activates YAP and promotes VSMCs proliferation and migration via Nrp2/PlexinA1. Cellular Signalling, 105, 110613. https://doi.org/10.1016/j.cellsig.2023.110613
Vancouver
Luo XY, Fu X, Liu F, Luo JY, Chen AF. Sema3G activates YAP and promotes VSMCs proliferation and migration via Nrp2/PlexinA1. Cellular Signalling. 2023;105:110613. doi:10.1016/j.cellsig.2023.110613
BibTeX
@article{Luo2023,
author = {Luo, Xue-Yang and Fu, Xiao and Liu, Fang and Luo, Jiang-Yun and Chen, Alex F},
title = {Sema3G activates YAP and promotes VSMCs proliferation and migration via Nrp2/PlexinA1},
journal = {Cellular Signalling},
year = {2023},
volume = {105},
pages = {110613},
doi = {10.1016/j.cellsig.2023.110613}
}
EUVIMED